,20 PKCζ activation also regulates hepatic steatosis, insulin resistance, and intrahepatic cholestasis.[21], [22], [23], [24], [25] However, the role of SHP in steatosis, inflammation, and BA homeostasis in patients with MASH remains unclear. Here, NR0B2 is linked to fatty liver disease.